Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Morgan

Showing results (271-280 of 307) with videos related to

Pageof 31
Sort By:
BJU International|November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosisFrancesco Soria, Peter C Black, Adrian S Fairey, et al.
Urology|December 15, 2021
Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical NeedJeffrey J Tosoian, Udit Singhal, Matthew S Davenport, et al.
JCO Clinical Cancer Informatics|May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III TrialsMack Roach, Jingbin Zhang, Osama Mohamad, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancerUdit Singhal, Ralph Jiang, James A Proudfoot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-AnalysisDaniel E Spratt, Shawn Malone, Soumyajit Roy, et al.
Prostate Cancer and Prostatic Diseases|April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifierJeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2020
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate CancerWilliam A Hall, Eric Paulson, Brian J Davis, et al.
JAMA Oncology|April 18, 2024
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate CancerJeffrey J Tosoian, Yuping Zhang, Lanbo Xiao, et al.
Cancer Discovery|March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate ImmunityAkash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
European Urology|December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG TrialsTodd M Morgan, Yi Ren, Siyi Tang, et al.
Pageof 31

Showing results (271-280 of 307) with videos related to

Sort By:
Pageof 31
BJU International|November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosisFrancesco Soria, Peter C Black, Adrian S Fairey, et al.
Urology|December 15, 2021
Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical NeedJeffrey J Tosoian, Udit Singhal, Matthew S Davenport, et al.
JCO Clinical Cancer Informatics|May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III TrialsMack Roach, Jingbin Zhang, Osama Mohamad, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancerUdit Singhal, Ralph Jiang, James A Proudfoot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-AnalysisDaniel E Spratt, Shawn Malone, Soumyajit Roy, et al.
Prostate Cancer and Prostatic Diseases|April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifierJeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2020
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate CancerWilliam A Hall, Eric Paulson, Brian J Davis, et al.
JAMA Oncology|April 18, 2024
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate CancerJeffrey J Tosoian, Yuping Zhang, Lanbo Xiao, et al.
Cancer Discovery|March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate ImmunityAkash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
European Urology|December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG TrialsTodd M Morgan, Yi Ren, Siyi Tang, et al.
Pageof 31